CompletedPhase 3

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

NCT00363727

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Anniston, Alabama, United States

+68 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2003-12
Enrollment: 209 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (69)

GSK Investigational SiteAnniston, Alabama, United States
GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SitePhoenix, Arizona, United States
GSK Investigational SiteSun City, Arizona, United States
GSK Investigational SiteTucson, Arizona, United States
GSK Investigational SiteLa Jolla, California, United States
GSK Investigational SiteLos Angeles, California, United States
GSK Investigational SiteNewport Beach, California, United States
GSK Investigational SiteOxnard, California, United States
GSK Investigational SiteSan Jose, California, United States
GSK Investigational SiteWalnut Creek, California, United States
GSK Investigational SiteBoulder, Colorado, United States
GSK Investigational SiteDanbury, Connecticut, United States
GSK Investigational SiteNewark, Delaware, United States
GSK Investigational SiteBoca Raton, Florida, United States
GSK Investigational SiteFort Lauderdale, Florida, United States
GSK Investigational SiteGainesville, Florida, United States
GSK Investigational SiteMiami, Florida, United States
GSK Investigational SitePalm Beach Gardens, Florida, United States
GSK Investigational SitePembroke Pines, Florida, United States
GSK Investigational SitePort Charlotte, Florida, United States
GSK Investigational SiteTampa, Florida, United States
GSK Investigational SiteTampa, Florida, United States
GSK Investigational SiteAugusta, Georgia, United States
GSK Investigational SiteAustell, Georgia, United States
GSK Investigational SiteColumbus, Georgia, United States
GSK Investigational SiteDecatur, Georgia, United States
GSK Investigational SiteBoise, Idaho, United States
GSK Investigational SiteChicago, Illinois, United States
GSK Investigational SiteChicago, Illinois, United States
GSK Investigational SiteHoffman Estates, Illinois, United States
GSK Investigational SiteNorthbrook, Illinois, United States
GSK Investigational SiteDes Moines, Iowa, United States
GSK Investigational SiteKansas City, Kansas, United States
GSK Investigational SiteElkridge, Maryland, United States
GSK Investigational SiteSouth Weymouth, Massachusetts, United States
GSK Investigational SiteWest Yarmouth, Massachusetts, United States
GSK Investigational SiteBingham Farms, Michigan, United States
GSK Investigational SiteGrand Rapids, Michigan, United States
GSK Investigational SiteTraverse City, Michigan, United States
GSK Investigational SiteLas Vegas, Nevada, United States
GSK Investigational SiteEdison, New Jersey, United States
GSK Investigational SiteAlbany, New York, United States
GSK Investigational SiteAmherst, New York, United States
GSK Investigational SiteRochester, New York, United States
GSK Investigational SiteAsheville, North Carolina, United States
GSK Investigational SiteChapel Hill, North Carolina, United States
GSK Investigational SiteRaleigh, North Carolina, United States
GSK Investigational SiteWinston-Salem, North Carolina, United States
GSK Investigational SiteCincinnati, Ohio, United States
GSK Investigational SiteEugene, Oregon, United States
GSK Investigational SiteMedford, Oregon, United States
GSK Investigational SitePhiladelphia, Pennsylvania, United States
GSK Investigational SiteAustin, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteLubbock, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteAlexandria, Virginia, United States
GSK Investigational SiteRichmond, Virginia, United States
GSK Investigational SiteRoanoke, Virginia, United States
GSK Investigational SiteKirkland, Washington, United States
GSK Investigational SiteSeattle, Washington, United States
GSK Investigational SiteTacoma, Washington, United States
GSK Investigational SiteCharleston, West Virginia, United States
GSK Investigational SiteMadison, Wisconsin, United States